Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Solutions × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 7 Other hematologic neoplasm 2 Gynecologic 2 CNS 2 Tumor-Agnostic 1 Sarcoma 1 Other 1 Head & Neck 1 Genitourinary 1 Endocrine 1

Conditions

Interventions

Cyclophosphamide 120 Radiotherapy 116 Temozolomide 103 Doxorubicin 84 Filgrastim 57 Ifosfamide 54 Gemcitabine 50 Etoposide 46 Imatinib Mesylate 45 fludarabine phosphate 44 Bevacizumab 43 pembrolizumab 39 Irinotecan 39 pazopanib 35 Peripheral Blood Stem Cell Transplantation 35 Busulfan 35 Methotrexate 34 Vincristine 33 Melphalan 33 Magnetic Resonance Spectroscopy 33 Carboplatin 33 Nivolumab 30 Cisplatin 30 Radiation 29 Surgical Procedures, Operative 28 Blood Specimen Collection 28 Docetaxel 27 Cyclosporine 27 Trabectedin 26 Mycophenolic Acid 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03886311 2025-02-24

TNT

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡